The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Pharmaceutical Formulation Development Market Research Report 2025

Global Pharmaceutical Formulation Development Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1715004

No of Pages : 115

Ask Your Query

Synopsis

Market Analysis and Insights: Global Pharmaceutical Formulation Development Market
The global Pharmaceutical Formulation Development market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.

Fully considering the economic change by this health crisis, Oral accounting for % of the Pharmaceutical Formulation Development global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital segment is altered to an % CAGR throughout this forecast period.

China Pharmaceutical Formulation Development market size is valued at US$ million in 2021, while the North America and Europe Pharmaceutical Formulation Development are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Pharmaceutical Formulation Development landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Pharmaceutical Formulation Development market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Pharmaceutical Formulation Development market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Pharmaceutical Formulation Development market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Pharmaceutical Formulation Development market.

Global Pharmaceutical Formulation Development Scope and Market Size
Pharmaceutical Formulation Development market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Pharmaceutical Formulation Development market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

  • Oral
  • External Use

Segment by Application

  • Hospital
  • Enterprise

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina, Colombia)

By Company

  • Lgm Pharma
  • Dalton Pharma Services
  • Recipharm
  • Aurigene Pharmaceutical Services
  • Coriolis Pharma
  • Intertek
  • Quay Pharma
  • Lonza
  • Ardena
  • Kemwell
  • Sgs
  • Syngene International
  • Piramal Pharma Solutions
  • Pharma Mo Ltd
  • Metrics Contract Services
  • Corealis Pharma
  • Element Materials Technology
  • Adare Pharma Solutions
  • Singota Solutions
  • Creative Biolabs
Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharmaceutical Formulation Development Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Oral
1.2.3 External Use
1.3 Market by Application
1.3.1 Global Pharmaceutical Formulation Development Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Enterprise
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Pharmaceutical Formulation Development Market Perspective (2017-2028)
2.2 Pharmaceutical Formulation Development Growth Trends by Region
2.2.1 Pharmaceutical Formulation Development Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Pharmaceutical Formulation Development Historic Market Size by Region (2017-2022)
2.2.3 Pharmaceutical Formulation Development Forecasted Market Size by Region (2023-2028)
2.3 Pharmaceutical Formulation Development Market Dynamics
2.3.1 Pharmaceutical Formulation Development Industry Trends
2.3.2 Pharmaceutical Formulation Development Market Drivers
2.3.3 Pharmaceutical Formulation Development Market Challenges
2.3.4 Pharmaceutical Formulation Development Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pharmaceutical Formulation Development Players by Revenue
3.1.1 Global Top Pharmaceutical Formulation Development Players by Revenue (2017-2022)
3.1.2 Global Pharmaceutical Formulation Development Revenue Market Share by Players (2017-2022)
3.2 Global Pharmaceutical Formulation Development Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Pharmaceutical Formulation Development Revenue
3.4 Global Pharmaceutical Formulation Development Market Concentration Ratio
3.4.1 Global Pharmaceutical Formulation Development Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmaceutical Formulation Development Revenue in 2021
3.5 Pharmaceutical Formulation Development Key Players Head office and Area Served
3.6 Key Players Pharmaceutical Formulation Development Product Solution and Service
3.7 Date of Enter into Pharmaceutical Formulation Development Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pharmaceutical Formulation Development Breakdown Data by Type
4.1 Global Pharmaceutical Formulation Development Historic Market Size by Type (2017-2022)
4.2 Global Pharmaceutical Formulation Development Forecasted Market Size by Type (2023-2028)
5 Pharmaceutical Formulation Development Breakdown Data by Application
5.1 Global Pharmaceutical Formulation Development Historic Market Size by Application (2017-2022)
5.2 Global Pharmaceutical Formulation Development Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Pharmaceutical Formulation Development Market Size (2017-2028)
6.2 North America Pharmaceutical Formulation Development Market Size by Country (2017-2022)
6.3 North America Pharmaceutical Formulation Development Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Pharmaceutical Formulation Development Market Size (2017-2028)
7.2 Europe Pharmaceutical Formulation Development Market Size by Country (2017-2022)
7.3 Europe Pharmaceutical Formulation Development Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pharmaceutical Formulation Development Market Size (2017-2028)
8.2 Asia-Pacific Pharmaceutical Formulation Development Market Size by Country (2017-2022)
8.3 Asia-Pacific Pharmaceutical Formulation Development Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Pharmaceutical Formulation Development Market Size (2017-2028)
9.2 Latin America Pharmaceutical Formulation Development Market Size by Country (2017-2022)
9.3 Latin America Pharmaceutical Formulation Development Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pharmaceutical Formulation Development Market Size (2017-2028)
10.2 Middle East & Africa Pharmaceutical Formulation Development Market Size by Country (2017-2022)
10.3 Middle East & Africa Pharmaceutical Formulation Development Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 LGM Pharma
11.1.1 LGM Pharma Company Detail
11.1.2 LGM Pharma Business Overview
11.1.3 LGM Pharma Pharmaceutical Formulation Development Introduction
11.1.4 LGM Pharma Revenue in Pharmaceutical Formulation Development Business (2017-2022)
11.1.5 LGM Pharma Recent Development
11.2 Dalton Pharma Services
11.2.1 Dalton Pharma Services Company Detail
11.2.2 Dalton Pharma Services Business Overview
11.2.3 Dalton Pharma Services Pharmaceutical Formulation Development Introduction
11.2.4 Dalton Pharma Services Revenue in Pharmaceutical Formulation Development Business (2017-2022)
11.2.5 Dalton Pharma Services Recent Development
11.3 Recipharm
11.3.1 Recipharm Company Detail
11.3.2 Recipharm Business Overview
11.3.3 Recipharm Pharmaceutical Formulation Development Introduction
11.3.4 Recipharm Revenue in Pharmaceutical Formulation Development Business (2017-2022)
11.3.5 Recipharm Recent Development
11.4 Aurigene Pharmaceutical Services
11.4.1 Aurigene Pharmaceutical Services Company Detail
11.4.2 Aurigene Pharmaceutical Services Business Overview
11.4.3 Aurigene Pharmaceutical Services Pharmaceutical Formulation Development Introduction
11.4.4 Aurigene Pharmaceutical Services Revenue in Pharmaceutical Formulation Development Business (2017-2022)
11.4.5 Aurigene Pharmaceutical Services Recent Development
11.5 Coriolis Pharma
11.5.1 Coriolis Pharma Company Detail
11.5.2 Coriolis Pharma Business Overview
11.5.3 Coriolis Pharma Pharmaceutical Formulation Development Introduction
11.5.4 Coriolis Pharma Revenue in Pharmaceutical Formulation Development Business (2017-2022)
11.5.5 Coriolis Pharma Recent Development
11.6 Intertek
11.6.1 Intertek Company Detail
11.6.2 Intertek Business Overview
11.6.3 Intertek Pharmaceutical Formulation Development Introduction
11.6.4 Intertek Revenue in Pharmaceutical Formulation Development Business (2017-2022)
11.6.5 Intertek Recent Development
11.7 Quay Pharma
11.7.1 Quay Pharma Company Detail
11.7.2 Quay Pharma Business Overview
11.7.3 Quay Pharma Pharmaceutical Formulation Development Introduction
11.7.4 Quay Pharma Revenue in Pharmaceutical Formulation Development Business (2017-2022)
11.7.5 Quay Pharma Recent Development
11.8 Lonza
11.8.1 Lonza Company Detail
11.8.2 Lonza Business Overview
11.8.3 Lonza Pharmaceutical Formulation Development Introduction
11.8.4 Lonza Revenue in Pharmaceutical Formulation Development Business (2017-2022)
11.8.5 Lonza Recent Development
11.9 Ardena
11.9.1 Ardena Company Detail
11.9.2 Ardena Business Overview
11.9.3 Ardena Pharmaceutical Formulation Development Introduction
11.9.4 Ardena Revenue in Pharmaceutical Formulation Development Business (2017-2022)
11.9.5 Ardena Recent Development
11.10 Kemwell
11.10.1 Kemwell Company Detail
11.10.2 Kemwell Business Overview
11.10.3 Kemwell Pharmaceutical Formulation Development Introduction
11.10.4 Kemwell Revenue in Pharmaceutical Formulation Development Business (2017-2022)
11.10.5 Kemwell Recent Development
11.11 SGS
11.11.1 SGS Company Detail
11.11.2 SGS Business Overview
11.11.3 SGS Pharmaceutical Formulation Development Introduction
11.11.4 SGS Revenue in Pharmaceutical Formulation Development Business (2017-2022)
11.11.5 SGS Recent Development
11.12 Syngene International
11.12.1 Syngene International Company Detail
11.12.2 Syngene International Business Overview
11.12.3 Syngene International Pharmaceutical Formulation Development Introduction
11.12.4 Syngene International Revenue in Pharmaceutical Formulation Development Business (2017-2022)
11.12.5 Syngene International Recent Development
11.13 Piramal Pharma Solutions
11.13.1 Piramal Pharma Solutions Company Detail
11.13.2 Piramal Pharma Solutions Business Overview
11.13.3 Piramal Pharma Solutions Pharmaceutical Formulation Development Introduction
11.13.4 Piramal Pharma Solutions Revenue in Pharmaceutical Formulation Development Business (2017-2022)
11.13.5 Piramal Pharma Solutions Recent Development
11.14 Pharma Mo Ltd
11.14.1 Pharma Mo Ltd Company Detail
11.14.2 Pharma Mo Ltd Business Overview
11.14.3 Pharma Mo Ltd Pharmaceutical Formulation Development Introduction
11.14.4 Pharma Mo Ltd Revenue in Pharmaceutical Formulation Development Business (2017-2022)
11.14.5 Pharma Mo Ltd Recent Development
11.15 Metrics Contract Services
11.15.1 Metrics Contract Services Company Detail
11.15.2 Metrics Contract Services Business Overview
11.15.3 Metrics Contract Services Pharmaceutical Formulation Development Introduction
11.15.4 Metrics Contract Services Revenue in Pharmaceutical Formulation Development Business (2017-2022)
11.15.5 Metrics Contract Services Recent Development
11.16 COREALIS Pharma
11.16.1 COREALIS Pharma Company Detail
11.16.2 COREALIS Pharma Business Overview
11.16.3 COREALIS Pharma Pharmaceutical Formulation Development Introduction
11.16.4 COREALIS Pharma Revenue in Pharmaceutical Formulation Development Business (2017-2022)
11.16.5 COREALIS Pharma Recent Development
11.17 Element Materials Technology
11.17.1 Element Materials Technology Company Detail
11.17.2 Element Materials Technology Business Overview
11.17.3 Element Materials Technology Pharmaceutical Formulation Development Introduction
11.17.4 Element Materials Technology Revenue in Pharmaceutical Formulation Development Business (2017-2022)
11.17.5 Element Materials Technology Recent Development
11.18 Adare Pharma Solutions
11.18.1 Adare Pharma Solutions Company Detail
11.18.2 Adare Pharma Solutions Business Overview
11.18.3 Adare Pharma Solutions Pharmaceutical Formulation Development Introduction
11.18.4 Adare Pharma Solutions Revenue in Pharmaceutical Formulation Development Business (2017-2022)
11.18.5 Adare Pharma Solutions Recent Development
11.19 Singota Solutions
11.19.1 Singota Solutions Company Detail
11.19.2 Singota Solutions Business Overview
11.19.3 Singota Solutions Pharmaceutical Formulation Development Introduction
11.19.4 Singota Solutions Revenue in Pharmaceutical Formulation Development Business (2017-2022)
11.19.5 Singota Solutions Recent Development
11.20 Creative Biolabs
11.20.1 Creative Biolabs Company Detail
11.20.2 Creative Biolabs Business Overview
11.20.3 Creative Biolabs Pharmaceutical Formulation Development Introduction
11.20.4 Creative Biolabs Revenue in Pharmaceutical Formulation Development Business (2017-2022)
11.20.5 Creative Biolabs Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables

List of Tables
Table 1. Global Pharmaceutical Formulation Development Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Oral
Table 3. Key Players of External Use
Table 4. Global Pharmaceutical Formulation Development Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 5. Global Pharmaceutical Formulation Development Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Pharmaceutical Formulation Development Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Pharmaceutical Formulation Development Market Share by Region (2017-2022)
Table 8. Global Pharmaceutical Formulation Development Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Pharmaceutical Formulation Development Market Share by Region (2023-2028)
Table 10. Pharmaceutical Formulation Development Market Trends
Table 11. Pharmaceutical Formulation Development Market Drivers
Table 12. Pharmaceutical Formulation Development Market Challenges
Table 13. Pharmaceutical Formulation Development Market Restraints
Table 14. Global Pharmaceutical Formulation Development Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Pharmaceutical Formulation Development Market Share by Players (2017-2022)
Table 16. Global Top Pharmaceutical Formulation Development Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Formulation Development as of 2021)
Table 17. Ranking of Global Top Pharmaceutical Formulation Development Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Pharmaceutical Formulation Development Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Pharmaceutical Formulation Development Product Solution and Service
Table 21. Date of Enter into Pharmaceutical Formulation Development Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Pharmaceutical Formulation Development Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Pharmaceutical Formulation Development Revenue Market Share by Type (2017-2022)
Table 25. Global Pharmaceutical Formulation Development Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Pharmaceutical Formulation Development Revenue Market Share by Type (2023-2028)
Table 27. Global Pharmaceutical Formulation Development Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Pharmaceutical Formulation Development Revenue Market Share by Application (2017-2022)
Table 29. Global Pharmaceutical Formulation Development Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Pharmaceutical Formulation Development Revenue Market Share by Application (2023-2028)
Table 31. North America Pharmaceutical Formulation Development Market Size by Country (2017-2022) & (US$ Million)
Table 32. North America Pharmaceutical Formulation Development Market Size by Country (2023-2028) & (US$ Million)
Table 33. Europe Pharmaceutical Formulation Development Market Size by Country (2017-2022) & (US$ Million)
Table 34. Europe Pharmaceutical Formulation Development Market Size by Country (2023-2028) & (US$ Million)
Table 35. Asia-Pacific Pharmaceutical Formulation Development Market Size by Region (2017-2022) & (US$ Million)
Table 36. Asia-Pacific Pharmaceutical Formulation Development Market Size by Region (2023-2028) & (US$ Million)
Table 37. Latin America Pharmaceutical Formulation Development Market Size by Country (2017-2022) & (US$ Million)
Table 38. Latin America Pharmaceutical Formulation Development Market Size by Country (2023-2028) & (US$ Million)
Table 39. Middle East & Africa Pharmaceutical Formulation Development Market Size by Country (2017-2022) & (US$ Million)
Table 40. Middle East & Africa Pharmaceutical Formulation Development Market Size by Country (2023-2028) & (US$ Million)
Table 41. LGM Pharma Company Detail
Table 42. LGM Pharma Business Overview
Table 43. LGM Pharma Pharmaceutical Formulation Development Product
Table 44. LGM Pharma Revenue in Pharmaceutical Formulation Development Business (2017-2022) & (US$ Million)
Table 45. LGM Pharma Recent Development
Table 46. Dalton Pharma Services Company Detail
Table 47. Dalton Pharma Services Business Overview
Table 48. Dalton Pharma Services Pharmaceutical Formulation Development Product
Table 49. Dalton Pharma Services Revenue in Pharmaceutical Formulation Development Business (2017-2022) & (US$ Million)
Table 50. Dalton Pharma Services Recent Development
Table 51. Recipharm Company Detail
Table 52. Recipharm Business Overview
Table 53. Recipharm Pharmaceutical Formulation Development Product
Table 54. Recipharm Revenue in Pharmaceutical Formulation Development Business (2017-2022) & (US$ Million)
Table 55. Recipharm Recent Development
Table 56. Aurigene Pharmaceutical Services Company Detail
Table 57. Aurigene Pharmaceutical Services Business Overview
Table 58. Aurigene Pharmaceutical Services Pharmaceutical Formulation Development Product
Table 59. Aurigene Pharmaceutical Services Revenue in Pharmaceutical Formulation Development Business (2017-2022) & (US$ Million)
Table 60. Aurigene Pharmaceutical Services Recent Development
Table 61. Coriolis Pharma Company Detail
Table 62. Coriolis Pharma Business Overview
Table 63. Coriolis Pharma Pharmaceutical Formulation Development Product
Table 64. Coriolis Pharma Revenue in Pharmaceutical Formulation Development Business (2017-2022) & (US$ Million)
Table 65. Coriolis Pharma Recent Development
Table 66. Intertek Company Detail
Table 67. Intertek Business Overview
Table 68. Intertek Pharmaceutical Formulation Development Product
Table 69. Intertek Revenue in Pharmaceutical Formulation Development Business (2017-2022) & (US$ Million)
Table 70. Intertek Recent Development
Table 71. Quay Pharma Company Detail
Table 72. Quay Pharma Business Overview
Table 73. Quay Pharma Pharmaceutical Formulation Development Product
Table 74. Quay Pharma Revenue in Pharmaceutical Formulation Development Business (2017-2022) & (US$ Million)
Table 75. Quay Pharma Recent Development
Table 76. Lonza Company Detail
Table 77. Lonza Business Overview
Table 78. Lonza Pharmaceutical Formulation Development Product
Table 79. Lonza Revenue in Pharmaceutical Formulation Development Business (2017-2022) & (US$ Million)
Table 80. Lonza Recent Development
Table 81. Ardena Company Detail
Table 82. Ardena Business Overview
Table 83. Ardena Pharmaceutical Formulation Development Product
Table 84. Ardena Revenue in Pharmaceutical Formulation Development Business (2017-2022) & (US$ Million)
Table 85. Ardena Recent Development
Table 86. Kemwell Company Detail
Table 87. Kemwell Business Overview
Table 88. Kemwell Pharmaceutical Formulation Development Product
Table 89. Kemwell Revenue in Pharmaceutical Formulation Development Business (2017-2022) & (US$ Million)
Table 90. Kemwell Recent Development
Table 91. SGS Company Detail
Table 92. SGS Business Overview
Table 93. SGS Pharmaceutical Formulation DevelopmentProduct
Table 94. SGS Revenue in Pharmaceutical Formulation Development Business (2017-2022) & (US$ Million)
Table 95. SGS Recent Development
Table 96. Syngene International Company Detail
Table 97. Syngene International Business Overview
Table 98. Syngene International Pharmaceutical Formulation DevelopmentProduct
Table 99. Syngene International Revenue in Pharmaceutical Formulation Development Business (2017-2022) & (US$ Million)
Table 100. Syngene International Recent Development
Table 101. Piramal Pharma Solutions Company Detail
Table 102. Piramal Pharma Solutions Business Overview
Table 103. Piramal Pharma Solutions Pharmaceutical Formulation DevelopmentProduct
Table 104. Piramal Pharma Solutions Revenue in Pharmaceutical Formulation Development Business (2017-2022) & (US$ Million)
Table 105. Piramal Pharma Solutions Recent Development
Table 106. Pharma Mo Ltd Company Detail
Table 107. Pharma Mo Ltd Business Overview
Table 108. Pharma Mo Ltd Pharmaceutical Formulation DevelopmentProduct
Table 109. Pharma Mo Ltd Revenue in Pharmaceutical Formulation Development Business (2017-2022) & (US$ Million)
Table 110. Pharma Mo Ltd Recent Development
Table 111. Metrics Contract Services Company Detail
Table 112. Metrics Contract Services Business Overview
Table 113. Metrics Contract Services Pharmaceutical Formulation DevelopmentProduct
Table 114. Metrics Contract Services Revenue in Pharmaceutical Formulation Development Business (2017-2022) & (US$ Million)
Table 115. Metrics Contract Services Recent Development
Table 116. COREALIS Pharma Company Detail
Table 117. COREALIS Pharma Business Overview
Table 118. COREALIS Pharma Pharmaceutical Formulation DevelopmentProduct
Table 119. COREALIS Pharma Revenue in Pharmaceutical Formulation Development Business (2017-2022) & (US$ Million)
Table 120. COREALIS Pharma Recent Development
Table 121. Element Materials Technology Company Detail
Table 122. Element Materials Technology Business Overview
Table 123. Element Materials Technology Pharmaceutical Formulation DevelopmentProduct
Table 124. Element Materials Technology Revenue in Pharmaceutical Formulation Development Business (2017-2022) & (US$ Million)
Table 125. Element Materials Technology Recent Development
Table 126. Adare Pharma Solutions Company Detail
Table 127. Adare Pharma Solutions Business Overview
Table 128. Adare Pharma Solutions Pharmaceutical Formulation DevelopmentProduct
Table 129. Adare Pharma Solutions Revenue in Pharmaceutical Formulation Development Business (2017-2022) & (US$ Million)
Table 130. Adare Pharma Solutions Recent Development
Table 131. Singota Solutions Company Detail
Table 132. Singota Solutions Business Overview
Table 133. Singota Solutions Pharmaceutical Formulation DevelopmentProduct
Table 134. Singota Solutions Revenue in Pharmaceutical Formulation Development Business (2017-2022) & (US$ Million)
Table 135. Singota Solutions Recent Development
Table 136. Creative Biolabs Company Detail
Table 137. Creative Biolabs Business Overview
Table 138. Creative Biolabs Pharmaceutical Formulation DevelopmentProduct
Table 139. Creative Biolabs Revenue in Pharmaceutical Formulation Development Business (2017-2022) & (US$ Million)
Table 140. Creative Biolabs Recent Development
Table 141. Research Programs/Design for This Report
Table 142. Key Data Information from Secondary Sources
Table 143. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pharmaceutical Formulation Development Market Share by Type: 2021 VS 2028
Figure 2. Oral Features
Figure 3. External Use Features
Figure 4. Global Pharmaceutical Formulation Development Market Share by Application in 2021 & 2028
Figure 5. Hospital Case Studies
Figure 6. Enterprise Case Studies
Figure 7. Pharmaceutical Formulation Development Report Years Considered
Figure 8. Global Pharmaceutical Formulation Development Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 9. Global Pharmaceutical Formulation Development Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 10. Global Pharmaceutical Formulation Development Market Share by Region: 2021 VS 2028
Figure 11. Global Pharmaceutical Formulation Development Market Share by Players in 2021
Figure 12. Global Top Pharmaceutical Formulation Development Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Formulation Development as of 2021)
Figure 13. The Top 10 and 5 Players Market Share by Pharmaceutical Formulation Development Revenue in 2021
Figure 14. North America Pharmaceutical Formulation Development Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 15. North America Pharmaceutical Formulation Development Market Share by Country (2017-2028)
Figure 16. United States Pharmaceutical Formulation Development Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 17. Canada Pharmaceutical Formulation Development Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 18. Europe Pharmaceutical Formulation Development Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. Europe Pharmaceutical Formulation Development Market Share by Country (2017-2028)
Figure 20. Germany Pharmaceutical Formulation Development Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. France Pharmaceutical Formulation Development Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. U.K. Pharmaceutical Formulation Development Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Italy Pharmaceutical Formulation Development Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Russia Pharmaceutical Formulation Development Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Nordic Countries Pharmaceutical Formulation Development Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Asia-Pacific Pharmaceutical Formulation Development Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Asia-Pacific Pharmaceutical Formulation Development Market Share by Region (2017-2028)
Figure 28. China Pharmaceutical Formulation Development Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Japan Pharmaceutical Formulation Development Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. South Korea Pharmaceutical Formulation Development Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Southeast Asia Pharmaceutical Formulation Development Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. India Pharmaceutical Formulation Development Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Australia Pharmaceutical Formulation Development Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Latin America Pharmaceutical Formulation Development Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Latin America Pharmaceutical Formulation Development Market Share by Country (2017-2028)
Figure 36. Mexico Pharmaceutical Formulation Development Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Brazil Pharmaceutical Formulation Development Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Middle East & Africa Pharmaceutical Formulation Development Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Middle East & Africa Pharmaceutical Formulation Development Market Share by Country (2017-2028)
Figure 40. Turkey Pharmaceutical Formulation Development Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Saudi Arabia Pharmaceutical Formulation Development Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. LGM Pharma Revenue Growth Rate in Pharmaceutical Formulation Development Business (2017-2022)
Figure 43. Dalton Pharma Services Revenue Growth Rate in Pharmaceutical Formulation Development Business (2017-2022)
Figure 44. Recipharm Revenue Growth Rate in Pharmaceutical Formulation Development Business (2017-2022)
Figure 45. Aurigene Pharmaceutical Services Revenue Growth Rate in Pharmaceutical Formulation Development Business (2017-2022)
Figure 46. Coriolis Pharma Revenue Growth Rate in Pharmaceutical Formulation Development Business (2017-2022)
Figure 47. Intertek Revenue Growth Rate in Pharmaceutical Formulation Development Business (2017-2022)
Figure 48. Quay Pharma Revenue Growth Rate in Pharmaceutical Formulation Development Business (2017-2022)
Figure 49. Lonza Revenue Growth Rate in Pharmaceutical Formulation Development Business (2017-2022)
Figure 50. Ardena Revenue Growth Rate in Pharmaceutical Formulation Development Business (2017-2022)
Figure 51. Kemwell Revenue Growth Rate in Pharmaceutical Formulation Development Business (2017-2022)
Figure 52. SGS Revenue Growth Rate in Pharmaceutical Formulation Development Business (2017-2022)
Figure 53. Syngene International Revenue Growth Rate in Pharmaceutical Formulation Development Business (2017-2022)
Figure 54. Piramal Pharma Solutions Revenue Growth Rate in Pharmaceutical Formulation Development Business (2017-2022)
Figure 55. Pharma Mo Ltd Revenue Growth Rate in Pharmaceutical Formulation Development Business (2017-2022)
Figure 56. Metrics Contract Services Revenue Growth Rate in Pharmaceutical Formulation Development Business (2017-2022)
Figure 57. COREALIS Pharma Revenue Growth Rate in Pharmaceutical Formulation Development Business (2017-2022)
Figure 58. Element Materials Technology Revenue Growth Rate in Pharmaceutical Formulation Development Business (2017-2022)
Figure 59. Adare Pharma Solutions Revenue Growth Rate in Pharmaceutical Formulation Development Business (2017-2022)
Figure 60. Singota Solutions Revenue Growth Rate in Pharmaceutical Formulation Development Business (2017-2022)
Figure 61. Creative Biolabs Revenue Growth Rate in Pharmaceutical Formulation Development Business (2017-2022)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock